Verteporfin in Photodynamic Therapy: report no. 5.
Bandello
Francesco
F
Blinder
Kevin
K
Bressler
Neil M
NM
Brown
Alison L
AL
Miller
Joan W
JW
Potter
Michael J
MJ
Pournaras
Constantin
C
Reaves
Al
A
Rosenfeld
Philip J
PJ
Slakter
Jason S
JS
Soubrane
Gisele
G
Strong
H Andrew
HA
Stur
Michael
M
D020256:Choroidal Neovascularization / Q000188:drug therapy* / Q000209:etiology; D005584:Fovea Centralis; D006801:Humans; D009216:Myopia / Q000150:complications*; D010778:Photochemotherapy; D017319:Photosensitizing Agents / Q000627:therapeutic use*; D011166:Porphyrins / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D000077362:Verteporfin; D014792:Visual Acuity / Q000502:physiology
D017319:Photosensitizing Agents; D011166:Porphyrins; D000077362:Verteporfin